Evidence map›Paper›PMID 28143936›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

EBI3 regulates the NK cell response to mouse cytomegalovirus infection.

Helle Jensen, Shih-Yu Chen, Lasse Folkersen, Garry P Nolan, Lewis L Lanier

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. KLF12 Regulates Mouse NK Cell Proliferation.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Helle JensenDepartment of Microbiology and Immunology, University of California, San Francisco, CA 94143.
Shih-Yu ChenDepartment of Microbiology and Immunology, Stanford University, Palo Alto, CA 94304.
Lasse FolkersenDepartment of Systems Biology, Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby DK-2800, Denmark.
Garry P NolanDepartment of Microbiology and Immunology, Stanford University, Palo Alto, CA 94304.
Lewis L LanierDepartment of Microbiology and Immunology, University of California, San Francisco, CA 94143; lewis.lanier@ucsf.edu.
Stanford University · USUniversity of California, San Francisco · USTechnical University of Denmark · DK

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
NK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0M
NK and T Cell Costimulation by NKG2D/DAP10R37AI066897 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2015
$3.8M
Balanced signaling cues to guide cell transitions in the blood lineage continuumR01HL120724 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAKRABORTY, ARUP K., NOLAN, GARRY P · 2015 to 2019
$3.7M
Stanford Technology Accelerating Medicines Partnership CenterUH2AR067676 · NIAMS · STANFORD UNIVERSITY · PI ROBINSON, WILLIAM H, UTZ, PAUL JOSEPH · 2014 to 2020
$2.6M
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian CancersR01CA184968 · NCI · STANFORD UNIVERSITY · PI FANTL, WENDY JANE, SIKIC, BRANIMIR I · 2014 to 2017
$2.0M
Highly multiplexed ion-beam tissue molecular imaging with sub-micron resolutionR33CA183654 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2014 to 2016
$1.2M
Integrating mass cytometric and transcriptomic profiles of solid tumorsR33CA183692 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2014 to 2016
$1.2M
Highly multiplexed ion-beam tissue RNA in situ imaging with sub-micron resolutionR21CA183660 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BOROWSKY, ALEXANDER D, LEVENSON, RICHARD M. · 2014 to 2015
$539k
NCI NIH HHS R01 CA184968NCI NIH HHS R21 CA183660NCI NIH HHS R33 CA183654NCI NIH HHS R33 CA183692NHLBI NIH HHS R01 HL120724NIAID NIH HHS R01 AI068129NIAID NIH HHS R37 AI066897NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI100627NIAMS NIH HHS UH2 AR067676
6 · The paper itself

Abstract

Natural killer (NK) cells are key mediators in the control of cytomegalovirus infection. Here, we show that Epstein-Barr virus-induced 3 (EBI3) is expressed by human NK cells after NKG2D or IL-12 plus IL-18 stimulation and by mouse NK cells during mouse cytomegalovirus (MCMV) infection. The induction of EBI3 protein expression in mouse NK cells is a late activation event. Thus, early activation events of NK cells, such as IFNγ production and CD69 expression, were not affected in EBI3-deficient (

Indexed as

AnimalsCell LineCells, CulturedCytomegalovirus InfectionsGene ExpressionHost-Pathogen InteractionsHumansInterleukin-12Interleukin-18Killer Cells, NaturalMice, Inbred C57BLMice, KnockoutMinor Histocompatibility AntigensMuromegalovirusReceptors, CytokineEbi3 protein, mouseInterleukin-12Interleukin-18Minor Histocompatibility AntigensReceptors, CytokinecytomegalovirusEBI3natural killer cell

Identifiers

PMID28143936
PMCPMC5321027
OpenAlexW2585641458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.